Sanofi India balance sheet

As of Dec 2025

Total assets: ₹1,255cr−22.1% on Dec 2024
Shareholders' equity: ₹749cr−12.9% on Dec 2024
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹263cr−7.4% on Dec 2024

₹ crore except per share

Tap a line for its trend	FY26Dec 2025	FY25Dec 2024	FY24Dec 2023	FY23Dec 2022	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	303	311	310	305
	11.6	18.1	13.3	18.8
	0.7	1.3	4.9	0.3
	0.0	—	2.6	4.8
	0.0	0.0	2.0	0.0
	6.8	12.7	11.1	14.7
	6.8	12.7	13.1	14.7
	4.4	0.1	—	—
	6.1	4.1	125	118
	333	348	469	461
	312	500	664	408
	177	230	132	129
	263	284	393	1,005
	12.0	11.0	12.0	12.0
	0.9	1.0	1.9	2.0
	2.8	45.2	7.8	7.0
	455	571	546	1,155
	33.7	55.9	36.2	46.3
	922	1,264	1,246	1,609
	0.0	—	—	1.0
	1,255	1,612	1,715	2,072
Equity
	23.0	23.0	23.0	23.0
	726	838	993	1,253
	749	861	1,016	1,276
	749	861	1,016	1,276
Liabilities
	0.0	14.0	13.9	14.9
	0.0	14.0	13.9	14.9
	13.7	0.0	30.7	35.5
	0.0	0.0	3.7	4.9
	0.5	18.0	—	0.0
	14.2	32.0	48.3	55.3
	194	406	292	356
	65.1	39.7	21.8	20.0
	259	446	313	376
	114	173	227	256
	95.7	95.9	102	90.0
	23.1	4.8	9.6	17.6
	491	719	651	740
	0.0	—	—	0.9
	506	751	700	796
	1,255	1,612	1,715	2,072
Assets — additional as-filed lines
	121	138	—	0.0
Trade payables — MSME split
	10.0	—	—	—
	184	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SANOFI₹2,992.00

Sanofi India Limited

· Pharma & Health

₹ CrorePeersSENORES INNOVACAP PGHL MOREPENLAB IOLCP SANOFICONR FDC ORCHPHARMAMcap ₹6,882 Cr

View

In ₹ Crore except Per Share As of	FY23 31/12/2022	FY24 31/12/2023	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	305.2	310.0	311.3	303.4	303.4
+ Capital Work-in-Progress	18.8	13.3	18.1	11.6	11.6
+ Other Intangibles	0.3	4.9	1.3	0.7	0.7
+ Intangibles under Development	4.8	2.6	—	0.0	0.0
+ Non-current Investments	0.0	2.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	14.7	11.1	12.7	6.8	6.8
Non-current Financial Assets	14.7	13.1	12.7	6.8	6.8
+ Deferred Tax Assets	—	—	0.1	4.4	4.4
+ Other Non-current Assets	117.6	124.9	4.1	6.1	6.1
Total Non-current Assets	461.4	468.8	347.6	333.0	333.0
Current Assets
+ Inventories	408.0	663.8	499.8	311.6	311.6
+ Trade Receivables	129.1	131.7	230.0	176.7	176.7
+ Cash & Cash Equivalents	1,004.9	392.9	283.8	262.9	262.9
+ Other Bank Balances	12.0	12.0	11.0	12.0	12.0
+ Short-term Loans	2.0	1.9	1.0	0.9	0.9
+ Other Current Financial Assets	7.0	7.8	45.2	2.8	2.8
Current Financial Assets	1,155.0	546.3	571.0	455.3	455.3
+ Other Current Assets	46.3	36.2	55.9	33.7	33.7
Total Current Assets	1,609.3	1,246.3	1,264.2	921.8	921.8
+ Assets Held for Sale	1.0	—	—	0.0	0.0
Total Assets	2,071.7	1,715.1	1,611.8	1,254.8	1,254.8
Equity
+ Equity Share Capital	23.0	23.0	23.0	23.0	23.0
+ Other Equity / Reserves	1,252.8	992.5	837.6	726.2	726.2
Equity — Owners of Parent	1,275.8	1,015.5	860.6	749.2	749.2
Total Equity	1,275.8	1,015.5	860.6	749.2	749.2
Liabilities
+ Other Non-current Financial Liab	14.9	13.9	14.0	0.0	0.0
Non-current Financial Liabilities	14.9	13.9	14.0	0.0	0.0
+ Provisions — Non-current	35.5	30.7	0.0	13.7	13.7
+ Deferred Tax Liabilities	4.9	3.7	0.0	0.0	0.0
+ Other Non-current Liabilities	0.0	—	18.0	0.5	0.5
Non-current Liabilities	55.3	48.3	32.0	14.2	14.2
+ Trade Payables	356.4	291.5	406.3	194.0	194.0
+ Other Current Financial Liab	20.0	21.8	39.7	65.1	65.1
Current Financial Liabilities	376.4	313.3	446.0	259.1	259.1
+ Provisions — Current	255.7	226.9	172.5	113.5	113.5
+ Current Tax Liabilities	90.0	101.5	95.9	95.7	95.7
+ Other Current Liabilities	17.6	9.6	4.8	23.1	23.1
Current Liabilities	739.7	651.3	719.2	491.4	491.4
+ Liabilities Held for Sale	0.9	—	—	0.0	0.0
Total Liabilities	795.9	699.6	751.2	505.6	505.6
Total Equity & Liabilities	2,071.7	1,715.1	1,611.8	1,254.8	1,254.8
Assets — additional as-filed lines
+ Current Tax Assets	0.0	—	137.5	121.2	121.2
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	—	10.0	10.0
+ Dues to Other Creditors — Current	—	—	—	184.0	184.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.